生产企业：Absci Corporation
ABS-201 is an early-stage, AI-designed injectable drug candidate developed by Absci for the treatment of pattern hair loss. The company expects interim data in the second half of 2026.
ABS-201 is an early-stage, AI-designed injectable drug candidate developed by Absci for the treatment of pattern hair loss. The company expects interim data in the second half of 2026.
共 1 项相关疾病
